Integer Welcomes Michael Coyle to Its Board of Directors
Integer Holdings Corporation (NYSE: ITGR), a leading player in the global medical device landscape, is thrilled to announce a significant addition to its Board of Directors with the appointment of Michael Coyle.
With over four decades of experience in the medical device sector, Coyle brings a wealth of knowledge and leadership capabilities, making him a valuable asset to Integer’s governance structure as a member of the Audit Committee, Compensation & Organization Committee, and Technology Strategy Committee.
Coyle's Impressive Background
Before joining Integer, Coyle was the president and CEO of iRhythm Technologies, a well-known name in digital healthcare innovation. His prior experience includes key executive roles at Medtronic, where he led the cardio and vascular group, along with positions at St. Jude Medical and Eli Lilly. This vast array of experience has honed his leadership skills and industry insight.
Significant Contributions Expected
Coyle is not only a seasoned executive but also an active director on several boards, including Haemonetics Corporation and BaroPace. His history of governance extends to previous Board roles with VNUS Medical Technologies and Volcano Corporation, showcasing his strategic insights gained throughout his career.
He holds a master’s degree in business administration from the Wharton School of Business at the University of Pennsylvania and a bachelor’s degree from Case Western Reserve University. Coyle also has an impressive portfolio with six U.S. patents in cardiovascular medical devices, further emphasizing his expertise.
Statements from Leadership
Pamela Bailey, Chair of the Board, expressed her enthusiasm, stating, "Integer’s Board regularly evaluates its composition to align with our objectives and to remain at the forefront of the medical device industry. We are delighted to welcome Michael Coyle, whose rich background in the medical device space will bolster our strategic direction and corporate culture."
Likewise, Joseph Dziedzic, the president and CEO of Integer, stated, "We are eager to collaborate with Michael as we continue executing our strategic objectives aimed at driving sustainable growth. His expertise will bolster our strategy in contract development and manufacturing, affirming our commitment to delivering innovative medical solutions and enhancing patient outcomes globally."
About Integer
Integer Holdings Corporation (NYSE: ITGR) stands as one of the largest medical device contract development and manufacturing organizations in the world. The company serves the cardiac rhythm management, neuromodulation, and cardiovascular markets. As the preferred partner for medical device companies and OEMs, Integer is dedicated to enhancing the quality of life for patients through innovative products and solutions. Their renowned brands include Greatbatch Medical and Lake Region Medical.
Integer’s commitment goes beyond just business; it focuses on improvement and innovation, influencing positive patient outcomes on a global scale.
Frequently Asked Questions
What is the significance of Michael Coyle joining Integer's Board?
Michael Coyle's appointment brings extensive medical device industry expertise, enhancing Integer's strategic direction and governance.
What roles will Michael Coyle serve at Integer?
Coyle will participate in the Audit Committee, Compensation & Organization Committee, and Technology Strategy Committee.
What is Integer Holdings Corporation known for?
Integer is recognized as a leading medical device contract development and manufacturing organization, focusing on innovative solutions to improve patient lives.
What educational background does Michael Coyle have?
Coyle holds an MBA from the Wharton School and a bachelor’s degree from Case Western Reserve University.
What other companies has Michael Coyle served?
He has held leadership positions in companies including Medtronic, iRhythm Technologies, and BaroPace.
